| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,594 |
7,511 |
$5.90M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,771 |
3,176 |
$3.27M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,129 |
3,798 |
$1.90M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,098 |
1,644 |
$1.68M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,916 |
9,223 |
$447K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
86 |
75 |
$201K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,867 |
1,051 |
$181K |
| 80053 |
Comprehensive metabolic panel |
9,440 |
7,790 |
$180K |
| 70450 |
Computed tomography, head or brain; without contrast material |
293 |
245 |
$116K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
876 |
619 |
$94K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,361 |
526 |
$76K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
112 |
105 |
$45K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,119 |
1,003 |
$43K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,412 |
1,886 |
$42K |
| 71046 |
Radiologic examination, chest; 2 views |
812 |
721 |
$38K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,609 |
2,844 |
$37K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,995 |
2,376 |
$24K |
| 85027 |
|
291 |
269 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
626 |
589 |
$13K |
| 0001A |
|
309 |
281 |
$12K |
| 0002A |
|
269 |
259 |
$11K |
| 97161 |
|
94 |
91 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
160 |
95 |
$11K |
| 81001 |
|
4,341 |
3,623 |
$11K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,478 |
1,129 |
$10K |
| 81025 |
|
1,783 |
1,612 |
$10K |
| 84550 |
|
752 |
670 |
$9K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
33 |
25 |
$9K |
| 85610 |
|
1,599 |
1,216 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
1,797 |
1,413 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
431 |
324 |
$6K |
| 85018 |
|
227 |
212 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
63 |
60 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
695 |
577 |
$5K |
| 0064A |
|
161 |
148 |
$5K |
| 0012A |
|
127 |
120 |
$5K |
| 0011A |
|
149 |
129 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
15,130 |
11,975 |
$3K |
| 0071A |
|
84 |
81 |
$3K |
| 0072A |
|
76 |
74 |
$3K |
| 86900 |
|
51 |
42 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,005 |
1,477 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
612 |
553 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
277 |
171 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
918 |
743 |
$2K |
| 83880 |
|
54 |
43 |
$2K |
| 0054A |
|
32 |
32 |
$1K |
| 0004A |
|
33 |
30 |
$1K |
| 97597 |
|
23 |
12 |
$1K |
| 97162 |
|
13 |
12 |
$1K |
| 84484 |
|
1,792 |
1,080 |
$717.75 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
44 |
12 |
$573.98 |
| 80076 |
|
20 |
16 |
$319.29 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
727 |
623 |
$304.40 |
| 83690 |
|
1,207 |
986 |
$299.34 |
| 81002 |
|
55 |
54 |
$282.12 |
| 0134A |
|
14 |
14 |
$171.76 |
| 85651 |
|
27 |
26 |
$72.08 |
| 96160 |
|
5,592 |
4,445 |
$58.90 |
| 83605 |
|
464 |
294 |
$52.16 |
| G0378 |
Hospital observation service, per hour |
27 |
12 |
$51.48 |
| 87040 |
|
140 |
63 |
$17.96 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
532 |
394 |
$17.32 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
800 |
612 |
$14.71 |
| 86140 |
|
35 |
30 |
$14.43 |
| 82948 |
|
49 |
40 |
$9.18 |
| 87070 |
|
128 |
115 |
$7.51 |
| 86850 |
|
49 |
42 |
$7.22 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
352 |
291 |
$6.45 |
| 86901 |
|
52 |
43 |
$2.73 |
| J9999 |
Not otherwise classified, antineoplastic drugs |
95 |
84 |
$2.00 |
| J3490 |
Unclassified drugs |
7,591 |
3,760 |
$0.84 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
119 |
89 |
$0.22 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
220 |
155 |
$0.12 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
30 |
27 |
$0.00 |
| 96161 |
|
2,041 |
1,817 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
823 |
723 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
15 |
12 |
$0.00 |
| 96376 |
|
169 |
120 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
17 |
15 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
44 |
39 |
$0.00 |
| 83735 |
|
38 |
29 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
113 |
97 |
$0.00 |
| 82962 |
|
16 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
16 |
12 |
$0.00 |
| A9150 |
Non-prescription drugs |
26 |
16 |
$0.00 |
| 85014 |
|
355 |
322 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
165 |
121 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17 |
16 |
$0.00 |
| S1015 |
Iv tubing extension set |
135 |
109 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
162 |
121 |
$0.00 |
| A9999 |
Miscellaneous dme supply or accessory, not otherwise specified |
95 |
86 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14 |
13 |
$0.00 |
| A4663 |
Blood pressure cuff only |
193 |
155 |
$0.00 |
| S5170 |
Home delivered meals, including preparation; per meal |
12 |
12 |
$0.00 |
| A4606 |
Oxygen probe for use with oximeter device, replacement |
115 |
103 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
16 |
12 |
$0.00 |
| 87186 |
|
27 |
16 |
$0.00 |